Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by JUBILANT DRAXIMAGE
FDA Drug Application 021305 by JUBILANT DRAXIMAGE
Application Number
021305
Application Type
New Drug Application
Sponsor Applicant
JUBILANT DRAXIMAGE
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New formulation
Therapeutic Potential
Standard
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
1/24/2003
N
4180
000
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21305ltr.pdf
1/24/2003
AP
0
1/24/2003
N
4181
000
http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21305_Sodium-Iodide_lbl.pdf
1/24/2003
AP
0
1/24/2003
N
6014
000
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021305_sodiumiodide.cfm
6/26/2003
AP
0
8/8/2003
SLR
6522
001
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21305slr001ltr.pdf
8/15/2003
AP
0
11/18/2004
SCS
10673
002
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21305s002ltr.pdf
12/2/2004
AP
0
5/19/2005
SE1
11670
003
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021305s003ltr.pdf
5/20/2005
AP
0
5/19/2005
SE1
11688
003
http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021305s003lbl.pdf
5/20/2005
AP
0
1/6/2006
SLR
13375
005
http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021305s005lbl.pdf
1/10/2006
AP
0
1/6/2006
SLR
13432
005
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021305s005ltr.pdf
1/20/2006
AP
0
10/23/2006
SLR
15254
010
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021305s010ltr.pdf
10/26/2006
AP
0
4/18/2007
SLR
16262
011
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021305s011lbl.pdf
4/20/2007
AP
0
4/18/2007
SLR
16307
011
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021305s011_LTR.pdf
4/25/2007
AP
0
2/29/2008
SLR
19357
016
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021305s016ltr.pdf
3/4/2008
AP
0
2/29/2008
SLR
19368
016
http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021305s016lbl.pdf
3/5/2008
AP
0
9/23/2011
SLR
30104
025
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021305s025ltr.pdf
9/28/2011
AP
0
9/23/2011
SLR
30127
025
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021305s025lbl.pdf
9/29/2011
AP
0
10/3/2011
SCM
30209
027
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021305s027lbl.pdf
10/3/2011
AP
0
10/3/2011
SCM
30222
027
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021305s027ltr.pdf
10/5/2011
AP
0
12/7/2012
SCM
AP
0
12/7/2012
SCM
AP
0
9/26/2014
SCM
AP
0
2/3/2015
SCM
AP
0
4/1/2016
SCM
AP
0
7/31/2015
SCM
AP
0
6/15/2016
SLR
46362
041
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021305Orig1s041ltr.pdf
6/21/2016
AP
0
6/15/2016
SLR
46376
041
http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021305s041lbl.pdf
6/21/2016
AP
0
7/8/2016
SLR
46508
042
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021305Orig1s042ltr.pdf
7/12/2016
AP
0
7/8/2016
SLR
46736
042
http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021305s042lbl.pdf
8/8/2016
Back to FDA Applications sponsored by JUBILANT DRAXIMAGE